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Introduction 
Accurate MRI characterization of myocardial iron is needed to improve the diagnosis and 
management of thalassaemia patients with transfusional iron overload. To prevent iron toxicity 
from inadequate chelation therapy and avoid the adverse effects of excessive chelator 
administration, reliable and sensitive monitoring of tissue iron is needed. In patients with iron 
overload, virtually all of the excess iron is sequestered within cells as short-term storage iron in 
ferritin (soluble nanometer-sized particles, dispersed and relatively uniformly distributed) and as 
long-term storage iron in hemosiderin (insoluble and clumped in irregular micron-sized clusters 
within siderosomes)1. Because cellular ferritin iron is in close equilibrium with the cytosolic iron 
pool involved in cellular injury2, measurement of myocardial ferritin iron may be valuable in 
assessing iron toxicity. Myocardial R2* is predominately influenced by hemosiderin iron and 
changes only slowly, after months of iron-chelating therapy3. Our study examined a new 
transverse relaxation index, the reduced R2 (RR2) that is estimated from non-monoexponential 
multi-echo CPMG signal decay4-6 and provides a measure of cellular ferritin iron. In 
thalassaemia patients examined at 3T, we found that RR2 could detect changes in myocardial 
ferritin iron after as little as 1 week (wk) of iron-chelating therapy. 
Methods 
Theory: In brief, the non-monoexponential CPMG signal decay in the presence of soluble and 
particulate iron is predicted to approximately follow: 
S(TE) = S0·exp(-RR2×TE)·exp(-A3/4×(ESP/2)3/4×TE3/8), 
where S(TE) is the signal amplitude at time TE, S0 is the initial signal amplitude and ESP is the 
interecho spacing. In tissues loaded with both ferritin and hemosiderin iron, RR2 is primarily 
sensitive to ferritin iron while A is predominately sensitive to hemosiderin iron4-6. 
MRI: A single-breathhold ECG-triggered turbo multi-echo spin-echo (MESE) sequence7-9 was 
implemented to measure CPMG signal decay on a 3T Philips MRI scanner with a 6-channel 
cardiac coil. One mid-ventricular short-axis slice with double-inversion black blood preparation 
was acquired with acquisition matrix = 128×96, turbo factor = 2, SENSE factor = 2, partial 
Fourier factor = 0.6, TR = 750-1200 ms, FOV = 370 mm, and slice thickness = 10 mm for 90º 
excitation and 30 mm for 180º refocusing. CPMG echo signal decays with 3 different interecho 
spacings (ESPs) (5, 9 and 13 ms; 6 echo images each) were acquired to estimate RR2. The 
acquisition was repeated five times, and RR2 measurements were averaged. For comparison, 
R2* measurement was performed in the same slice location using a single-breathhold ECG-
triggered multi-echo gradient-echo sequence (MEGE)7,10 with first TE = 1.55 ms, echo spacing 1 
ms, echo number = 25, flip angle = 20º, turbo field echo factor = 4 and black-blood preparation. 
Patients and 1-wk suspension of iron chelation: Thalassaemia patients with transfusional iron 
overload (N = 8; mean age = 29.3 ± 8.6 yrs) receiving regular iron chelation (deferoxamine, 30 
to 50 mg/kg for 2 to 5 days weekly +/- deferiprone, 55 to 95 mg/kg daily) were recruited. 
Cardiac MR was performed immediately before discontinuing iron chelation for 1 wk (Day 0), 
after 1-wk suspension of chelation (Day 7), and one week after resuming chelation (Day 14).  
Data Analysis: Identical ROIs in septum were used with slight position adjustments to account 
for motion among different breathholds. CPMG MESE signal decays of 3 different ESPs were 
fitted to the non-monoexponential equation above with floating noise for RR2 measurement. R2 
and R2* were measured by monoexponential fitting of signal decays (5 ms ESP for R2) with 
floating noise. 
Results and Discussions 
The sequence was first validated by measuring R2 in phantoms of varying concentrations of 
MnCl2 (0 to 1 mM with 0.1 mM increments) in 2% agarose gel, with 1s TR and 5 ms ESP. R2 
increased linearly (R = 0.99) with MnCl2 concentrations, indicating the robustness of R2 
measurement by the turbo MESE protocol implemented. The transverse relaxivity was measured 
as 103.5 s-1mM-1 at 3T (in contrast to 73.6 s-1mM-1 previously reported for 1.5T for aqueous MnCl211). Fig. 1 shows typical septum ROI delineation and the 
corresponding MESE signal decays from the 5 repeated scans. Fig. 2 shows the R2*, R2, and RR2 changes in patients before (Day 0), and after chelation suspension 
(Day 7) and then 1 wk after resuming iron chelation (Day 14). Significant differences in R2 and RR2 were observed between Day 0 and 7, and between Day 7 and 14, 
with RR2 yielding stronger significance. This finding indicates that transverse relaxation rate R2 and RR2, especially RR2, are more sensitive in detecting changes in 
myocardial iron. This is likely a result of their superior sensitivity to soluble ferritin iron that is in close equilibrium with the cytosolic iron pool that is expected to 
change during the 1-wk suspension of chelation. Note that no significant difference was found in R2 computed with other ESPs (i.e., 9 and 13 ms) as well as the 
average of 3 R2 values computed from 3 ESPs. For comparison, no significant differences in R2* were found. R2* is predominantly determined by hemosiderin iron 
that would be little changed by the brief suspension of iron-chelating therapy. These results are qualitatively consistent with a recent study by Kim et al at 1.5T.12 
Conclusion 
The experimental findings in this study demonstrated that RR2 measurement could detect myocardial iron changes associated with a brief (1 wk) suspension of iron-
chelating therapy in thalassaemia patients.  Therefore, MRI measurement of myocardial ferritin iron using RR2 may provide a new means of rapidly monitoring the 
effectiveness of iron-chelating therapy in transfusional iron overload. 
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Fig. 1. Typical ROI delineation in ventricular septum and the 
corresponding CPMG MESE signal decay of five repeated scans. 
Fig. 2. Measured R2*, R2 (using 5 ms ESP), and RR2 values at Day 
0 (on regular chelation), Day 7 (off chelation for 1 wk), and Day 14 
(on chelation again for 1 wk). Repeated measures ANOVA was 
performed with * for P < 0.05, ** for P < 0.01, n.s. for insignificance.
